What's happening in and around the Park? Here is an update from the team at the Illinois Science + Technology Park.    
ISTP Ownership Changes
A venture of Hallandale Beach, Fla.-based TopMed Realty bought the 233,588 -square-foot office building at 4901 Searle Parkway. The building, which is almost fully leased to NorthShore University HealthSystem on a long-term deal, was purchased from a venture of Skokie-based American Landmark Properties

The sale comes a month after American Landmark sold the life sciences lab portion (8025 and 8045 Lamon Ave.), the majority of the leased 22.6-acre ISTP campus to Chicago-based investor Singerman Real Estate. The portfolio is comprised of a mix of highly technical wet lab and GMP space and is home to established global life sciences brands as well as prestigious university affiliated venture backed startups.

These recent sales highlight property types for which real estate investors have clamored during the COVID-19 pandemic: high-quality life sciences research buildings and office buildings with big, single tenants with good credit and long-term leases. The former has benefited from a rush of venture capital pouring into biotech and pharmaceutical research throughout the public health crisis, while the latter has drawn buyers looking for safe places to invest amid economic uncertainty.

Noted Sam DiFrancesca and Lucas Borges of the JLL Capital Markets team....

“We were encouraged by the depth of capital with an interest in Greater Chicago and are excited to see such an established national life sciences investor as Singerman committing to the market,”

"The level of lender interest in this portfolio is further testament to Chicago’s significant growth potential within the life sciences space.”

Max Zwolan and Scott Brandwein of JLL also supported the transaction and will continue to handle the leasing for the buyers.
NuMat Technologies - Entrepreneurship Honor
NuMat Technologies Honored by Goldman Sachs for Entrepreneurship: Ben Hernandez, CEO, Among 100 Most Intriguing Entrepreneurs at 2021 Builders + Innovators Summit

 NuMat Technologies is a chemistry design company that enables its partners in the electronics, life-science, and industrial sectors to achieve sustainability and innovation objectives, one molecule at a time. A pioneer in the field of programmable chemistries, NuMat designs materials to capture targeted molecules in industrial products and processes where purity matters most. From reducing greenhouse gas emissions in the chemicals value-chain, to purifying electronic materials used in semiconductor manufacturing, NuMat is solving critical industrial challenges at the smallest possible level..

“I’m honored to receive this award on behalf of the incredibly talented NuMat team. True innovation is hard and we’re grateful to Goldman Sachs for recognizing NuMat’s leadership in applying programmable chemistries to solve the problems that matter. We’re excited to continue executing on our vision of using chemistry to deliver transformational solutions that address generational challenges.”" stated Ben Hernandez, Founder and Chief Executive Officer at NuMat Technologies.
Space Now Available @ISTP
There is laboratory and office space available in 8045 Lamon.  Suites, ranging from approximately 10,000 sq. ft. to over 50,000 sq. ft., are ready now. Options appropriately address your access and security concerns.  Interested? Click here!

8045 Lamon (Research to Commercialization)
  • 4 story, 163,000 square feet
  • Gold LEED rated “green” facility
  • Conference Center and Auditorium
  • Areas for meetings, collaboration and socialization

Design your customized lab & office facilities at 8030 Lamon. (Flexible Options for Development)
  • Flexible build to suit options
  • Up to 200,000 square feet of office and development space

“The Illinois Science + Technology Park is a significant contributor to Skokie’s employment base and economic growth,” said Skokie Mayor George Van Dusen. “The park continues to grow and contribute to Skokie’s economy while also providing economic stimulus for the state and Midwest region.”
Skokie Small Business Saturday & Week
Skokie Small Business Week (Saturday, November 27, 2021 through Friday, December 3, 2021)

Calling all Downtown Skokie supporters! Residents, daytime workers, visitors and out of town guests continue to show support for the many businesses who are emerging from these uncertain times The event has been stretched into Small Business WEEK (Nov. 27 - Dec. 3) and anyone who shops, dines or has a service performed at ANY Downtown Skokie business can take a selfie or group photo while there and send it in to info@skokie.org to be eligible for daily $20 gift certificates from a variety of merchants. For more information, click here.
Vetter: The Role of The CDMO's
Peter Soelkner shares his insights on the impact of new trends and molecules, and how Vetter is adapting to stay ahead.

The global market for injectable medications is more dynamic than ever, driven by surging demand, a new generation of complex drug products, and the accelerating shift from in-clinic to at-home care.

In this video, Peter Soelkner, one of Vetter’s managing directors, sat down with Stephanie Sutton of The Medicine Maker to discuss some of these key trends - and how Vetter is adapting to fast-changing market and patient needs.

As Peter Soelkner explains, the injectable drug market is seeing rapid growth in both the customization and complexity of new parenteral medications. While these new products often deliver innovative treatments for long-unmet needs, they also pose unique technical and operational challenges for manufacturers like Vetter.
“We support over 80 products registered with various agencies,” Soelkner noted. “It’s a lot of responsibility, but also extremely rewarding to be part of that supply chain. It’s a meaningful job that makes a difference in the lives of patients and their families.”

LanzaTech's Paradigm Shifting Plan
LanzaTech, a wholly innovative and unique company originally hailing from New Zealand and now based in Skokie, Illinois, is using a combination of cutting-edge genetic engineering, state-of-the-art artificial intelligence, and innovations in mechanical and chemical engineering to manufacture chemicals using a process that soaks up carbon rather than emitting it.

Because LanzaTech’s manufacturing process is so different from legacy methods, its business model is also very different.

LanzaTech is a perfect portrait of a company operating in what is termed the “Post-Carbon Industrial” sector. Its innovations shift industrial paradigms as much as steam engines did in the Second Industrial Revolution. Its business model shifts commercial paradigms as much as personal computers did during the Internet Revolution.

LanzaTech has completely rethought the process of manufacturing the chemicals essential to our high living standards and has successively partnered with carbon-emitters around the world to build fully functioning, revenue-generating chemical production facilities using the innovative process.

The brilliant team at LanzaTech know that to maintain the high standards of living we enjoy in the developed world and bring up the standards of living in developing areas, we simply cannot continue to operate according to obsolete paradigms. Humanity sets itself apart from other species with its creativity, adaptability, and intelligence; capitalism rewards these traits in spades.
Cour Pharma Expands at ISTP
To meet the increasing demand for medical research space in the Chicagoland area, Cour Pharmaceuticals' life science and emerging biotechnology footprint is expanding within the Illinois Science and Technology Park in Skokie, Ill. With the addition, Cour Pharmaceuticals now leases around 25,000 sq. ft. in the park.

COUR Pharmaceuticals is developing first-in-class therapies designed to reprogram the immune system to achieve antigen-specific tolerance for immune-mediated disease. COUR's platform of immune-modifying nanoparticles treats the root cause of immune disease, unlike traditional approaches, which only minimize symptoms using toxic immune suppression.
"Continued rapid growth for high-potential life science startups are emerging in Chicago and in addition to talent, life sciences companies like COUR will continue to need access to more specialized wet and dry lab space along with capital," said COUR Pharmaceuticals CEO John Puisis

CDMOs Gear Up
Ever alert to new opportunities, contract development and manufacturing organizations (CDMOs) are well aware that cell and gene therapies are generating excitement among industry analysts. For example, Deloitte recently predicted that the cell and gene therapy market will generate revenues of $12 billion a year by 2025, which is an impressive jump for a market valued at just $1 billion three years ago. Deloitte indicated that its prediction was based on the high level of activity in cell and gene therapy R&D—more than 1,000 clinical trials were ongoing in 2019—and the large number of developers entering the space.

Charles River Laboratories (CRL), long known as a research services firm, says that it is expanding its manufacturing business while pursuing a “technology agnostic” strategy that emphasizes innovation and flexibility. To read the entire article, click here.
Says Mike Austin, corporate vice president, Global Operations Cell and Gene Therapy CDMO Services, CRL. "Our combined capabilities allow clients to bring their cell and gene therapies from early research and discovery all the way through commercialization in a single, streamlined program.”
Northwestern Eyes Increased Research Funding
Rebecca Blank becomes Northwestern University's first female president.

Blank said increasing research funding, enhancing the residential university experience, and encouraging students to break out of the Evanston bubble are among some of the ideas she'd like to explore in her role. She declined to lay out more specific strategies, saying that will come later after she's had a chance to hear from students, faculty and senior leadership about what they think should be prioritized.

"Universities that are great do not stay in their ivory towers," she said. "They're constantly reaching out—not just to their local community, but to their global community, and interacting both with their research and their students."
Check out Skokie and ISTP
Living a CarbonSmart Life